e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of polymorphisms in genes involved in nicotine dependence pathways on the smoking burden of COPD patients
I. Costa Da Silva (Sao Paulo, Brazil), F. Arrabal Fernandes (Sao Paulo, Brazil), C. Dinardo (Sao Paulo, Brazil), R. Carvalho-Pinto (Sao Paulo, Brazil), C. Farias (Sao Paulo, Brazil), A. Cukier (Sao Paulo, Brazil)
Source:
International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Session:
New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Session type:
Thematic Poster
Number:
4053
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Costa Da Silva (Sao Paulo, Brazil), F. Arrabal Fernandes (Sao Paulo, Brazil), C. Dinardo (Sao Paulo, Brazil), R. Carvalho-Pinto (Sao Paulo, Brazil), C. Farias (Sao Paulo, Brazil), A. Cukier (Sao Paulo, Brazil). Impact of polymorphisms in genes involved in nicotine dependence pathways on the smoking burden of COPD patients. 4053
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
The influence of smoking on COPD phenotypes
Source: Eur Respir J 2004; 24: Suppl. 48, 20s
Year: 2004
The influence of smoking on hydrolipoperoxidation in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 306s
Year: 2003
Effect of smoking on lung functions in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 157s
Year: 2005
Role of TRPM8 polymorphisms in predisposition to COPD development in smokers
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020
The tobacco smoking influence on parodontic inflammation in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 167s
Year: 2007
Associations between genetic polymorphisms and drug response phenotypes in patients with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007
The influence of smoking on the treatment response in patients with asthma
Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients
Year: 2007
TNF promoter polymorphisms are associated with susceptibility and increased severity in secondary to tobacco and biomass smoke COPD in Mexican population
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
SNPs which influence the transcriptional response to acute smoke exposure are associated with long term lung function decline in smokers
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
The impact of smoking on the platelets functional activity in patients with COPD
Source: International Congress 2017 – COPD biomarkers
Year: 2017
Influence of smoking intensity and smoking quitting on lung function parameters in COPD patients
Source: Annual Congress 2011 - Smoking cessation science and smoking-related disorders
Year: 2011
beta2-Adrenoceptor polymorphisms and asthma phenotypes: interactions with passive smoking
Source: Eur Respir J 2008; 31: 479-480
Year: 2008
The association of high nicotine metabolism ratio with COPD in smokers undergoing a smoking cessation program.
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020
Factors associated with current smoking in COPD patients
Source: International Congress 2017 – Respiratory and exercise physiology
Year: 2017
Perception of the role of smoking in patients with COPD
Source: Annual Congress 2008 - The biology of smoking and COPD
Year: 2008
Impact of smoking and lung alterations on aging related manifestations in HIV patients.
Source: International Congress 2017 – Rare diseases
Year: 2017
Influence of active smoking on systemic TNF-α concentration in COPD patients
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
The effect of smoking on the activity of inflammatory markers in patients with COPD
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
HTR2A genetic variants as risk factors for cigarette smoking at an early age and relapse to smoking cessation treatment.
Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Year: 2018
Motivation of smokers and patients with smoking related diseases: the case of COPD
Source: ERS Course 2015
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept